Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D)
Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D)
Recruiting · NCT04187599 · Registry updated 2019-12-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D) | eye disorder, myopia, refractive error | Recruiting | Not applicable | 2019-12-05 | NCT04187599 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CooperVision International Limited (CVIL) | 10 |
| TigerMed | 3 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Changsha Aier Eye Hospital | Shanghai | China | 1 |
| Eye & Ent Hospital of Fudan University | Shanghai | China | 9 |
| The Affiliated Eye Hospital of Wenzhou Medical University | Wenzhou | China | 1 |
| Tianjin Eye Hospital | Tianjin | China | 5 |